Filing Flows › CareDx (CDNA) › Q3 2026 › vs Q3 2025
CareDx (CDNA) Q3 2026 vs Q3 2025 (year over year)
CareDx's revenue rose $39.3M (+39%) from $100M in Q3 2025 to $139M in Q3 2026. The biggest changes: Testing services revenue +$47.0M (+65%); Patient and digital solutions revenue +$4.8M (+31%). Operating margin 5.8% against -0.2% (+6.1 pts).
CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 5.8% | -0.2% | +6.1 pts |
| Net margin | 13.8% | 1.7% | +12.2 pts |
| Free cash flow margin | 8.0% | 36.0% | -28.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Testing services revenue | $119M | $72.2M | $47.0M | +65% |
| Patient and digital solutions revenue | $20.2M | $15.4M | $4.8M | +31% |
| Revenue | $139M | $100M | $39.3M | +39% |
| Other income, net | $2.6M | $1.9M | $674K | +35% |
| Operating profit | $8.1M | −$246K | $8.4M | — |
| Costs & expenses | $131M | $100M | $30.9M | +31% |
| Pre-tax earnings | $10.7M | $1.7M | $9.0M | +544% |
| Research & development | $21.3M | $16.8M | $4.6M | +27% |
| Sales & marketing | $31.6M | $24.4M | $7.2M | +29% |
| General & admin | $38.0M | $28.4M | $9.6M | +34% |
| Other operating costs | $40.3M | $30.7M | $9.6M | +31% |
| Income tax benefit | $8.6M | $15K | $8.6M | 573× |
| Net earnings | $19.3M | $1.7M | $17.6M | 12× |
| Operating cash sources | $36.2M | $13.9M | $22.2M | +160% |
| Depreciation & amortization | $7.2M | $3.8M | $3.4M | +89% |
| Share-based compensation | $9.7M | $8.4M | $1.2M | +15% |
| Working capital & other | $23.4M | −$23.5M | $46.9M | — |
| Operating cash flow | $12.7M | $37.4M | −$24.6M | -66% |
| Free cash flow (OCF − capex) | $11.1M | $36.1M | −$24.9M | -69% |
| Capital expenditures | $1.6M | $1.3M | $310K | +24% |
Questions
How much did CareDx's revenue grow year over year in Q3 2026?
CareDx's revenue rose $39.3M (+39%) from $100M in Q3 2025 to $139M in Q3 2026.
What drove CareDx's revenue change in Q3 2026?
Testing services revenue +$47.0M (+65%); Patient and digital solutions revenue +$4.8M (+31%).